Skip to main content
PreveCeutical Medical logo

PreveCeutical Medical — Investor Relations & Filings

Ticker · PREV ISIN · CA74143C1068 LEI · 96760001OJCSH5MXZ450 CSE Professional, scientific and technical activities
Open in API
Filings indexed 438 across all filing types
Latest filing 2020-07-21 Regulatory Filings
Country CA Canada
Listing CSE PREV

About PreveCeutical Medical

https://www.preveceutical.com/

PreveCeutical Medical Inc. is a health sciences company dedicated to the research and development of innovative options for preventive and curative therapies. The company specializes in utilizing organic and nature identical products, combining scientific rigor with natural sources to benefit health-conscious consumers. Its primary focus is on the preventive health sector, collaborating with partners to bring novel solutions to market.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings
2020-07-21 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing progress in a research and development program related to gene therapy for diabetes and obesity. It contains no financial statements, no regulatory form references, no voting results, no management or board changes, no earnings data, and no detailed financial or governance information. The content is primarily a corporate update on scientific progress and forward-looking statements. The document length is 7060 characters, which is sufficient to be more than a brief announcement but it does not contain substantive financial or regulatory report content. Therefore, it does not fit into categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. It is best classified as a Regulatory Filings (RNS) type, which is the fallback for miscellaneous corporate announcements and updates that do not fit other categories.
2020-07-15 English
News release - English.pdf
Regulatory Filings
2020-07-13 English
News release - English.pdf
Regulatory Filings
2020-07-08 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing the results of a stability study from a product development program related to a cannabinoid sol-gel formulation. It contains no financial statements, no regulatory filings, no voting results, no management or board changes, no earnings data, and no detailed financial or operational analysis. It is a corporate announcement about research and development progress and future plans, typical of a news release or general corporate update. The document length is 8431 characters, which is sufficient for a substantive announcement but it does not contain financial or regulatory report content. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. It is best classified as a Regulatory Filings (RNS) type, which is the fallback for miscellaneous corporate announcements and news releases that do not fit other categories.
2020-07-06 English
News release - English.pdf
Regulatory Filings
2020-06-29 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.